Product Description
The global ENT navigation system market was valued at $415 million in 2024. This is expected to increase over the forecast period at a CAGR of 4.2% to reach $550 million in 2031.
The full report suite on the global market for ear, nose and throat (ENT) navigation systems includes three segments: capital equipment, disposables and other accessories and services and maintenance revenue. Regional volumes of ENT procedures using a navigation system are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
The use of navigation systems is not considered the standard of care for all ENT procedures. New technology is constantly being developed to increase the accuracy of procedures at an economically viable price level. Since navigation systems are costly, bulky and require additional training, this may limit new unit sales. However, as more studies are published highlighting the benefit of navigated procedures compared with freehand procedures, more healthcare facilities will purchase image-guided surgery (IGS) systems to improve patient wellbeing and safety, driving the overall market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ENT NAVIGATION SYSTEMS MARKET TRENDS
The regions that saw the highest procedure volume in 2024 were North America and Western Europe, followed by Asia-Pacific. Over the forecast period, Asia-Pacific is expected to overtake North America in procedure volume, due to its higher compound annual growth rate (CAGR). North America is anticipated to see low-single-digit growth year over year. Moreover, disposables and other accessories was the largest segment of the overall ENT navigation system market, followed by services and maintenance. The capital equipment segment is the smallest in the overall market with the fastest growth rate. The services and maintenance segment is expected to grow the second-fastest in the overall market, while disposables and other accessories will grow at the slowest rate. Over the forecast period, capital equipment and services and maintenance are expected to take up a larger proportion of the overall market share, while disposables and other accessories is predicted to lose some share to the other segments.
GLOBAL ENT NAVIGATION SYSTEMS MARKET SHARE INSIGHTS
- Medtronic led the global ENT navigation system market in 2024. The company offers StealthStation™ S8, a navigation system that can be used for spinal, cranial, ENT and orthopedic procedures. Additionally, the company offers ENT-specific solutions, including the StealthStation™ ENT, StealthStation FlexENT™, FUSION™ and FUSION Compact™
- Brainlab occupied the second-leading position globally in the ENT navigation system market in 2024. It offers two IGS systems, the multi-specialty Kick® and Curve™, the latter of which is available with two monitors. While both systems have applications for ENT procedures, the Kick® system is more commonly used.
- Stryker was the third-leading competitor in the global ENT navigation system market in 2024. The company’s Stryker NAV3i® platform is suitable for many applications; it can be used in spinal, cranial, ENT and orthopedic procedures. In addition to its own product, Stryker also offers Scopis’ TGS® Target Guided Surgery Navigation System with an ENT application focus following Scopis Medical’s acquisition by Stryker in November 2017.
GLOBAL ENT MAVIGATION SYSTEMS MARKET SEGMENTATION SUMMARY
- Capital Equipment
- Disposables and Other Accessories
- Services and Maintenance Revenue
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
